HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN

Oncology

Cilta-cel CARTITUDE-4 Trial to be Unblinded After Meeting Primary End Point

Cilta-cel demonstrated a significant improvement in progression-free survival over standards of care.

CGTLive’s Weekly Rewind – January 27, 2023

Review top news and interview highlights from the week ending January 27, 2023.

Matt Angel, PhD, on Addressing Unmet Needs in Acute Myeloid Leukemia and Solid Tumors

The chief executive officer and president of Eterna Therapeutics discussed the company’s new collaboration with the University of Texas MD Anderson Cancer Center.